Evidence map›Paper›PMID 32489641›Full record

ArticlePulmonary circulation

Mechanical forces alter endothelin-1 signaling: comparative ovine models of congenital heart disease.

Terry Zhu, Samuel Chiacchia, Rebecca J Kameny, Antoni Garcia De Herreros, Wenhui Gong, Gary W Raff, Jason B Boehme, Emin Maltepe, Juan C Lasheras, Stephen M Black and 2 more

Open access · goldAbstract read
In one paragraph

Article in Pulmonary circulation. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Terry ZhuDepartment of Pediatrics, University of California, San Francisco, CA, USA.
Samuel ChiacchiaDepartment of Pediatrics, University of California, San Francisco, CA, USA.
Rebecca J KamenyDepartment of Pediatrics, University of California, San Francisco, CA, USA.
Antoni Garcia De HerrerosInstitute of Engineering in Medicine, University of California, San Diego, CA, USA.
Wenhui GongDepartment of Pediatrics, University of California, San Francisco, CA, USA.
Gary W RaffDepartment of Surgery, University of California, Davis, CA, USA.
Jason B BoehmeDepartment of Pediatrics, University of California, San Francisco, CA, USA.
Emin MaltepeDepartment of Pediatrics, University of California, San Francisco, CA, USA.
Juan C LasherasInstitute of Engineering in Medicine, University of California, San Diego, CA, USA.
Stephen M BlackDepartment of Medicine, University of Arizona, Tucson, AZ, USA.
Sanjeev A DatarDepartment of Pediatrics, University of California, San Francisco, CA, USA.
Jeffrey R FinemanDepartment of Pediatrics, University of California, San Francisco, CA, USA.
University of California, San Francisco · USUniversity of California, San Diego · USUniversity of Arizona · USUniversity of California, Davis · US

Funding

TGF-ß-SOX18-Collagen metabolism in pulmonary vascular disease associated with CHDP01HL146369 · NHLBI · UNIVERSITY OF ARIZONA · PI JEFFREY R FINEMAN · 2020 to 2026
$18.7M
Protein Chemistry & Biophysics CoreP01HL134610 · NHLBI · UNIVERSITY OF ARIZONA · PI BLACK, STEPHEN M · 2018 to 2022
$11.6M
PERINATAL PULMONARY HYPERTENSION: DEVELOPMENT MEDIATORSR01HL061284 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FINEMAN, JEFFREY R · 1999 to 2016
$8.3M
Altered Lymphatic Function and Development in Congenital Heart DiseaseR01HL133034 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Sanjeev A. Datar · 2016 to 2026
$6.4M
Research Training in Pediatric Critical Care MedicineT32HD049303 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JEFFREY R FINEMAN · 2006 to 2026
$3.1M
Perinatal NO signaling in congenital heart diseaseR01HL137282 · NHLBI · UNIVERSITY OF ARIZONA · PI BLACK, STEPHEN M, FINEMAN, JEFFREY R · 2017 to 2020
$2.7M
Comparing Ovine Models of Congenital Heart Disease to Distinguish Pathobiological Mechanisms Underlying Pulmonary Vascular Disease: Toward Precision Medicine for CHDK08HL146933 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KAMENY, REBECCA JOHNSON · 2019 to 2019
$180k
NHLBI NIH HHS K08 HL146933NHLBI NIH HHS P01 HL134610NHLBI NIH HHS P01 HL146369NHLBI NIH HHS R01 HL061284NHLBI NIH HHS R01 HL133034NHLBI NIH HHS R01 HL137282NICHD NIH HHS T32 HD049303
6 · The paper itself

Abstract

The risk and progression of pulmonary vascular disease in patients with congenital heart disease is dependent on the hemodynamics associated with different lesions. However, the underlying mechanisms are not understood. Endothelin-1 is a potent vasoconstrictor that plays a key role in the pathology of pulmonary vascular disease. We utilized two ovine models of congenital heart disease: (1) fetal aortopulmonary graft placement (shunt), resulting in increased flow and pressure; and (2) fetal ligation of the left pulmonary artery resulting in increased flow and normal pressure to the right lung, to investigate the hypothesis that high pressure and flow, but not flow alone, upregulates endothelin-1 signaling. Lung tissue and pulmonary arterial endothelial cells were harvested from control, shunt, and the right lung of left pulmonary artery lambs at 3-7 weeks of age. We found that lung preproendothelin-1 mRNA and protein expression were increased in shunt lambs compared to controls. Preproendothelin-1 mRNA expression was modestly increased, and protein was unchanged in left pulmonary artery lambs. These changes resulted in increased lung endothelin-1 levels in shunt lambs, while left pulmonary artery levels were similar to controls. Pulmonary arterial endothelial cells exposed to increased shear stress decreased endothelin-1 levels by five-fold, while cyclic stretch increased levels by 1.5-fold. These data suggest that pressure or an additive effect of pressure and flow, rather than increased flow alone, is the principal driver of increased endothelin signaling in congenital heart disease. Defining the molecular drivers of the pathobiology of pulmonary vascular disease due to differing mechanical forces will allow for a more targeted therapeutic approach.

Indexed as

angiogenesisapoptosispulmonary arterial hypertensionpulmonary endotheliumpulmonary hypertension

Identifiers

PMID32489641
PMCPMC7238833
OpenAlexW3025477637

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.